Conventional CARs versus modular CARs

The clinical application of immune effector cells genetically modified to express chimeric antigen receptors (CARs) has shown impressive results including complete remissions of certain malignant hematological diseases. However, their application can also cause severe side effects such as cytokine r...

Descripción completa

Detalles Bibliográficos
Autores principales: Feldmann, Anja, Arndt, Claudia, Koristka, Stefanie, Berndt, Nicole, Bergmann, Ralf, Bachmann, Michael P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Focussed Research Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805801/
https://www.ncbi.nlm.nih.gov/pubmed/31542798
http://dx.doi.org/10.1007/s00262-019-02399-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805801/
https://www.ncbi.nlm.nih.gov/pubmed/31542798
http://dx.doi.org/10.1007/s00262-019-02399-5

Ejemplares similares